Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,007Revenue $M1,249Net Margin (%)-0.5Z-Score3.6
Enterprise Value $M1,115EPS $-3.1Operating Margin %-0.1F-Score3
P/E(ttm))0Cash Flow Per Share $23.4Pre-tax Margin (%)-0.6Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsN
Price/Sales0.85-y EBITDA Growth Rate %0Current Ratio0.8Lower Leverage y-yN
Price/Cash Flow0.5y-y EBITDA Growth Rate %0ROA % (ttm)-0.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-1.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M33.4ROI % (ttm)-16.6Gross Margin Increase y-yN

Gurus Latest Trades with AMED

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMEDJoel Greenblatt 2014-12-31 Buy 0.01%$19.59 - $30.07
($24.78)
$ 30.1722%New holding, 23349 sh.23,349
AMEDCharles Brandes 2014-12-31 Sold Out $19.59 - $30.07
($24.7)
$ 30.1722%Sold Out0
AMEDCharles Brandes 2014-09-30 Reduce-0.03%$15.58 - $21.78
($19.38)
$ 30.1756%Reduce -90.43%15,810
AMEDCharles Brandes 2014-03-31 Reduce-0.01%$14.09 - $16.96
($15.31)
$ 30.1797%Reduce -23.43%165,125
AMEDCharles Brandes 2013-03-31 Add0.03%$10.95 - $13.11
($11.61)
$ 30.17160%Add 515.74%225,885
AMEDCharles Brandes 2012-12-31 Buy $9.65 - $13.56
($11.33)
$ 30.17166%New holding, 36685 sh.36,685
AMEDJoel Greenblatt 2012-12-31 Sold Out -0.06%$9.65 - $13.56
($11.33)
$ 30.17166%Sold Out0
AMEDJoel Greenblatt 2012-09-30 Reduce-0.06%$11.3 - $15.84
($13.63)
$ 30.17121%Reduce -49.75%65,015
AMEDCharles Brandes 2012-09-30 Sold Out -0.0017%$11.3 - $15.84
($13.63)
$ 30.17121%Sold Out0
AMEDJohn Hussman 2012-06-30 Sold Out -0.04%$9.87 - $15.03
($12.43)
$ 30.17143%Sold Out0
AMEDJoel Greenblatt 2012-03-31 Add0.09%$9.56 - $14.66
($11)
$ 30.17174%Add 98.71%144,813
AMEDCharles Brandes 2012-03-31 Buy $9.56 - $14.66
($11)
$ 30.17174%New holding, 20195 sh.20,195
AMEDDavid Dreman 2011-12-31 Sold Out -0.5%$9.59 - $14.56
($11.75)
$ 30.17157%Sold Out0
AMEDGeorge Soros 2011-12-31 Sold Out -0.0041%$9.59 - $14.56
($11.75)
$ 30.17157%Sold Out0
AMEDCharles Brandes 2011-12-31 Sold Out -0.0021%$9.59 - $14.56
($11.75)
$ 30.17157%Sold Out0
AMEDJoel Greenblatt 2011-09-30 Add0.09%$13.29 - $27.55
($19.78)
$ 30.1752%Add 125.99%64,379
AMEDGeorge Soros 2011-09-30 Reduce-0.07%$13.29 - $27.55
($19.78)
$ 30.1752%Reduce -91.93%16,100
AMEDGeorge Soros 2011-06-30 Buy 0.07%$25.28 - $35.18
($30.9)
$ 30.17-2%New holding, 199599 sh.199,599
AMEDJoel Greenblatt 2011-06-30 Add0.02%$25.28 - $35.18
($30.9)
$ 30.17-2%Add 21.45%28,488
AMEDCharles Brandes 2011-06-30 Buy $25.28 - $35.18
($30.9)
$ 30.17-2%New holding, 14350 sh.14,350
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMED is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AMED Joel Greenblatt 2014-12-3123,3490.070.01New Buy
AMED Charles Brandes 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AMED: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JETER JEFFREY DChief Compliance Officer 2014-08-05Sell2,500$21.838.39view
NORTH TIDE CAPITAL, LLC10% Owner 2014-05-08Buy500,000$13.9117.05view
NORTH TIDE CAPITAL, LLC10% Owner 2014-05-01Buy150,000$13.54122.82view
NORTH TIDE CAPITAL, LLC10% Owner 2014-04-29Sell0$0122.82view
RICCHIUTI PETERDirector 2014-04-02Sell375$15.3197.06view
RICCHIUTI PETERDirector 2014-03-04Sell400$16.6780.98view
RICCHIUTI PETERDirector 2013-12-03Sell375$15.8989.87view
KKR Asset Management LLC10% Owner 2013-11-21Buy425,515$14.48108.36view
Bucey David RGeneral Counsel and Secretary 2013-11-15Sell8,290$13.95116.27view
KKR Asset Management LLC10% Owner 2013-11-14Buy946,500$13.89117.21view

Press Releases about AMED :

    Quarterly/Annual Reports about AMED:

    News about AMED:

    Articles On GuruFocus.com
    comment on AMED Jun 20 2012 
    well undervalued, st Jan 24 2012 
    “Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
    AMED: Investment Opportunity When the Price Hits an 8-Year Low Dec 27 2011 
    Almost Family: The Magic Formula Stock is getting cheaper and cheaper Dec 11 2011 
    guru bargain Oct 05 2011 
    Magic Formula Stock: Amedisys (AMED) Aug 05 2011 
    Home Healthcare: Heavily Shorted long Opportunity May 30 2011 
    Amedisys Inc (AMED) CFO Dale E Redman buys 1,000 Shares Aug 25 2010 
    Amedisys Inc Reports Operating Results (10-Q) Aug 09 2010 


    More From Other Websites
    Amsurg (AMSG) Beats Q4 Earnings, Revenues; Outlook Bright - Analyst Blog Feb 26 2015
    Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date Feb 25 2015
    Amedisys Announces Clinical Excellence in Speech Language Pathology Feb 25 2015
    China Cord Blood Corp (CO) Jumps: Stock Up 9.5% - Tale of the Tape Feb 20 2015
    Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date Feb 19 2015
    Amedisys Chief Medical Officer, Michael Fleming, MD, FAAFP, States We Can Do Right by Patients at... Feb 12 2015
    Amedisys Chief Medical Officer, Michael Fleming, MD, FAAFP, States We Can Do Right by Patients at... Feb 12 2015
    Anthem Shares Fall Post Huge Data Breach, China Suspected - Analyst Blog Feb 06 2015
    Quest Diagnostics Strong on Earnings, Long-Term Prospects - Analyst Blog Feb 06 2015
    Quest Diagnostics Q4 Earnings, Revenues Beat; Grow Y/Y - Analyst Blog Jan 29 2015
    DaVita's Inorganic Growth Initiatives Look Impressive - Analyst Blog Jan 16 2015
    AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 15 2015
    Amedisys Updates Impact of 2015 Medicare Home Health Prospective Payment System Final Rule Jan 15 2015
    Amedisys Updates Impact of 2015 Medicare Home Health Prospective Payment System Final Rule Jan 15 2015
    Amedisys is Looking for Tuck-ins in the Wake of Its Restructuring Jan 15 2015
    AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure Jan 14 2015
    Amedisys to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 08 2015
    Amedisys to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 08 2015
    Amedisys Board Names Paul B. Kusserow as New CEO Dec 16 2014
    AMEDISYS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Dec 16 2014
    Amedisys Board Names Paul B. Kusserow as New CEO Dec 16 2014
    AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure Dec 10 2014
    Amedisys to Present at the 25th Annual Oppenheimer Healthcare Conference Dec 10 2014
    Amedisys to Present at the 25th Annual Oppenheimer Healthcare Conference Dec 10 2014
    The Right Time to Invest in Amedisys (AMED)? Dec 09 2014
    Amedisys upgraded by RBC Capital Mkts Dec 01 2014
    Market Has Not Yet Noticed Potential in Amedisys (AMED); Have You? Nov 28 2014
    Amedisys Inc. (AMED): Strong Industry, Solid Earnings Estimate Revisions Nov 21 2014
    2014 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide Nov 05 2014
    Amedisys beats Street 3Q forecasts Oct 29 2014
    Amedisys Announces Third Quarter Earnings Release and Conference Call Date Oct 16 2014
    Feds: Amedisys paying $150 million settlement Apr 23 2014
    Amedisys Expands Its Board of Directors with Appointment of KKR’s Nathaniel M. Zilkha Mar 27 2014
    Amedisys Announces Appointment of Dale E. Redman as Interim Chief Financial Officer Mar 19 2014
    Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date Mar 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK